

Summary: U.S. stock futures mixed, Dow futures down 0.1%. AirSculpt Technologies shares fell 13.4% after reporting Q2 results in-line with estimates. Other...
You can purchase shares of X4 Pharmaceuticals (NASDAQ:XFOR) through any online brokerage.
Other companies in X4 Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
X4 Pharmaceuticals has a consensus price target of $12.71.
The stock price for X4 Pharmaceuticals (NASDAQ: XFOR) is $3.3 last updated October 28, 2026 at 1:47 PM EDT.
There are no upcoming dividends for X4 Pharmaceuticals.
X4 Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for X4 Pharmaceuticals.
X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine...